CGC241122C8000
- 0.01
- 0.000.00%
Canopy Growth Newsroom
Tom Angell Says "DEA Says It Is in the Process of Preparing Public Access to the Cannabis Rescheduling Proceedings Docket. For Now, Read Marijuana Moment's Coverage of the Latest Significant Filings:", 'DEA And Anti-Marijuana Group Deny Allegations...
Canopy Growth's German Subsidiary Teams Up With Portugal's Gro-Vida To Expand Medical Cannabis Supply
What's Happening With Canopy Growth: Is It Time To Buy?
German Cannabis: 20 Tons, 10M Grams - And That's Only 0.3% Of The Market, What's Missing?
Cannabis Stocks Feel The Burn: Matt Gaetz Bows Out As Trump's Attorney General Nominee
The U.S. Cannabis Strategy No One's Talking About: Inside Canopy's $300M Plan
Canopy Growth, Aurora And Another Cannabis Giant Unveil Product Innovations, Here's What's New
STORZ & BICKEL Crowned Gold Medalists at 2024 MarCom Awards
Canopy Growth Brief: Launching Claybourne Infused Pre-Rolls in Canada
Canopy Growth Launches Claybourne Infused Pre-Rolls in Canada
US Manufacturing Index Rises To 43, Highest Since 2020
Canopy Growth Acquisition Target Acreage Reports 30% YoY Decline In Q3, Record Cannabis Wholesale Revenue In NY
Gaetz as Trump's AG Seen as Bullish for Pot Stocks, but Confirmation Looks Unlikely
Shares of Cannabis-linked Stocks Are Trading Higher After Chris Christie in a Benzinga Exclusive Suggested He Thinks Trump May Attempt to Change Marijuana to a Non-scheduled Drug That Wouldn't Be Illegal.
Health Care Up on Another Round of Mixed Earnings -- Health Care Roundup
Piper Sandler Underweight Canopy Growth
Canopy Growth Shares Are Trading Lower. The Company Reported Q2 Financial Results.
Canopy Growth Corporation (CGC) Q2 2025 Earnings Call Transcript
Green Thumb Industries Looks Past 'Tricky Time' for Cannabis Stocks as the Company Notches Another Profit
Canopy Growth Shares Drop as Canadian Adult-Use Cannabis Drags Total Revenue in 2Q